Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

The Use of PARP Inhibitors in Breast Cancer: Challenges
The Use of PARP Inhibitors in Breast Cancer: Challenges
by calandra-battersby
and Opportunities. This program will include a di...
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
by ellena-manuel
Program Overview . Discussion Outline. DNA Repair...
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
by conchita-marotz
PARP Inhibitors: What Do We know?. PARP Inhibitor...
PARP Inhibitors and Cancer: What Do You Need to Know?
PARP Inhibitors and Cancer: What Do You Need to Know?
by pasty-toler
This program will include a discussion of off-lab...
by medshair
Five-year . survival. 15%. 30%. 40%. ?50%?. First ...
by littleccas
actual. . video-recorded proceedings from the . l...
Cancer Chemotherapy Part I: General Cancer Chemotherapy
Cancer Chemotherapy Part I: General Cancer Chemotherapy
by ellena-manuel
Chapter 16; Pages 797 to 815A. also Section 16.11...
A Cancer
A Cancer
by stefany-barnette
Knowledge Network. Accelerate . cancer R&D. B...
Updates in Ovarian Cancer Care
Updates in Ovarian Cancer Care
by tatiana-dople
Lisa McCluskey, MD. Gynecologic Oncologist. June ...
Updates in Ovarian Cancer Care
Updates in Ovarian Cancer Care
by ellena-manuel
Lisa McCluskey, MD. Gynecologic Oncologist. June ...
GU CONNECT PARP inhibitors in Prostate Cancer
GU CONNECT PARP inhibitors in Prostate Cancer
by jocelyn
Latest developments. . Prof.. . Neeraj Agarwal, ...
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
by zen
knowledge. ). Incorporate evidence-based research ...
Please note, these are the actual video-recorded
Please note, these are the actual video-recorded
by blindnessinfluenced
proceedings from the live CME event and may includ...
Patient Selection for PARP
Patient Selection for PARP
by sherrill-nordquist
Inhibitors:. Purpose and Practicalities . Present...
The Nurse View: Clinical Considerations in the Management of
The Nurse View: Clinical Considerations in the Management of
by natalia-silvester
BRCA. -Mutated Advanced Ovarian Cancer. Moderator...
Precision Medicine in the management of gynecologic cancers
Precision Medicine in the management of gynecologic cancers
by stefany-barnette
Randal West, MD. Ovarian cancer standard of care....
State of the Art in BRCA
State of the Art in BRCA
by ellena-manuel
-Mutated Ovarian Cancer. This program will includ...
A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy
A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy
by bikersjoker
patients with . advanced breast . cancer and a ger...
Case Discussion: Second
Case Discussion: Second
by celsa-spraggs
Opinion. 55 year-old woman with . recurrent . ova...
Growth Patterns and Pathobiology of Experimental and
Growth Patterns and Pathobiology of Experimental and
by pamella-moone
Clinical Malignancies. In Vivo. Updated: March . ...
PCR Application:
PCR Application:
by alexa-scheidler
Can Breast Cancer be Cured?. Normal, Healthy Cell...